PsyPost
No Result
View All Result
PsyPost
No Result
View All Result
Home Exclusive Mental Health

PTSD symptoms may be prevented with a single dose of the drug ketamine

by Columbia University Medical Center
February 9, 2017
in Mental Health
(Photo credit: Alexandr Mitiuc/Fotolia)

(Photo credit: Alexandr Mitiuc/Fotolia)

[Subscribe to PsyPost on YouTube to stay up-to-date on the latest developments in psychology and neuroscience]

Share on FacebookShare on Twitter

Columbia University Medical Center (CUMC) researchers have found that a single dose of ketamine, given one week before a stressful event, can buffer against a heightened fear response.

The study, conducted in mice, suggests that prophylactic administration of ketamine–a drug commonly used as general anesthetic or a rapid-acting antidepressant–might prevent post-traumatic stress disorder (PTSD) symptoms in soldiers and others who subsequently experience psychological trauma.

The study was published online in January in the journal Neuropsychopharmacology.

“Ketamine is a powerful drug, and we wouldn’t advocate widespread use for preventing or reducing PTSD symptoms. But if our results in mice translate to humans, giving a single dose of ketamine in a vaccine-like fashion could have great benefit for people who are highly likely to experience significant stressors, such as members of the military or aid workers going into conflict zones,” said study leader Christine A. Denny, PhD, assistant professor of clinical neurobiology in Psychiatry at CUMC.

There are few effective therapies for preventing or treating PTSD, an anxiety disorder that occurs in about one-quarter of individuals who experience psychological trauma. PTSD symptoms include re-living the trauma–experiencing repeated flashbacks, hyperarousal, and hyperreactivity–as well as mood changes, psychological numbing, and chronic physical symptoms such as headache. The likelihood that symptoms will develop depends on the nature and intensity of the trauma and an individual’s response.

Previous studies, in both humans and animals, have shown that giving ketamine before trauma can help reduce stress-related symptoms. However, it was not clear when the drug should be administered relative to a traumatic episode in order to maximize its protective effects.

In the current study, mice were given a small dose of intravenous ketamine or a placebo either one month, one week, or one hour before they were subjected to a series of small shocks. The mice–conditioned to associate the test environment with the shocks–were later returned to the same environment and assessed for their freezing behavior, a measure of their conditioned fear response.

Only the mice given ketamine one week before the stressor exhibited reduced freezing when they were returned to the test environment. “Our findings indicate that the timing of ketamine administration is critical for buffering fear expression,” said first author Josephine C. McGowan, a student at Barnard College when the study was performed and now a doctoral student in Neurobiology and Behavior at CUMC.

It is not known whether there is an intermediate window, between one week and one hour, where ketamine would also have a protective effect.

The researchers also found that giving ketamine immediately after the stressor did not affect the animals’ fear response. However, giving ketamine one hour after a second shock decreased fear expression, suggesting that there may be another potential window after the initial trauma when the drug may be effective.

Dr. Denny’s team is currently studying how ketamine works in the brain to influence the response to stress. The CUMC researchers hope to study prophylactic ketamine use in humans, ideally among military personnel.

ShareTweetSendScanShareSharePinSend

Get all the latest updates on new psychology research with the free PsyPost app.
 


NEWSLETTER SIGN-UP

STAY CONNECTED

TRENDING

Love isn’t blind: Romantic partners are fairly accurate judges of their better half’s abilities, study indicates

Coffee drinking is largely unrelated to psychological well-being, according to new research

Adolescents without depressive symptoms show a bias toward faces with positive emotions

Study suggests shared reality plays a critical role in stressor reactivity among women

Mothers’ depressive symptoms appear to affect children’s socio-emotional development, partly through parenting practices

Neuroscience research suggests LSD might enhance learning and memory by promoting brain plasticity

RECENT

Researchers identify specific neural networks that are activated by religious worship

Study finds economic inequality promotes belief in conspiracy theories

Study among Roman Catholic clergy and nuns suggests spiritual openness may facilitate better mental health

Love isn’t blind: Romantic partners are fairly accurate judges of their better half’s abilities, study indicates

Adolescents without depressive symptoms show a bias toward faces with positive emotions

  • Cognitive Science
  • COVID-19
  • Mental Health
  • Social Psychology
  • Drug Research
  • Conspiracy Theories
  • Meditation
  • Psychology of Religion
  • Aviation Psychology and Human Factors
  • Relationships and Sexual Health
Powered by

About

PsyPost is a psychology and neuroscience news website dedicated to reporting the latest research on human behavior, cognition, and society. (READ MORE...)

  • Contact us
  • Privacy policy

No Result
View All Result
  • About
    • Newsletter signup form
  • Cart
  • Checkout
  • Contact
  • Contact us
  • My account
  • Privacy policy
  • Psychology news
  • PsyPost app privacy policy
  • Shop
  • SmartMag Home

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

This website uses cookies. By continuing to use this website you are giving consent to cookies being used.